Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LAZERTINIB vs LECANEMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LAZERTINIB vs LECANEMAB: Safety Overview

Metric LAZERTINIB LECANEMAB
Total FAERS Reports 352 171
Deaths Reported 15 27
Death Rate 4.3% 15.8%
Hospitalizations 83 101
Average Patient Age 66.6 yrs 74.2 yrs
% Female Patients 59.9% 64.1%
FDA Approval Date Aug 19, 2024 N/A
Manufacturer Janssen Biotech, Inc. Eisai Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription N/A